Latest Content

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.

Premiums for coverage on the ACA marketplaces are set to jump by an average of 26% next year, even before the expiration of subsidies is factored in.

The antiretroviral (ART) regimen Biktarvy showed higher 1-year ART persistence and lower switch rates among people with HIV.

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies to enhance patient care and outcomes.

Cancer care evolves with innovative therapies and financial challenges, emphasizing the need for equitable access and sustainable models in treatment delivery.

Real-world evidence helps pharmaceutical companies and payers communicate more effectively.

Oncology experts discuss the rapid advancements in cancer diagnostics and treatments, emphasizing the need for equitable access and infrastructure improvements.

Metabolic intermediates were identified as active participants in fibrosis progression and potential targets for next-generation therapies.